A phase 3 open label study of the sufentanil sublingual tablet 30 mcg for treatment of acute post-operative pain

Harold Minkowitz

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility